Research Article
Olfactory Neuroblastomas: An Experience of 24 Years
Table 3
Treatment modalities.
| Patient no. | Surgical procedure | CTX | Duration of CTX (Months) | Total radiotherapy fraction (Gy) |
| 1 | Craniofacial resection | | | 50 | 2 | — | cisplatin + etoposid | 8 | 56 | 3 | Craniofacial resection | | | 65 | 4 | — | cisplatin + etoposid ndoxan + vincristin + doxorubicin | 12 | 65 | 5 | — | | | 60 | 6 | Craniofacial resection | | | 50 | 7 | — | | | 60 | 8 | Maxillectomi + Orbital exenteration | | | 50 | 9 | Craniofacial resection | | | 36 | 10 | — | | | 66 | 11 | Craniofacia resection | cisplatin + etoposid | 5 | 60 | 12 | Craniofacial resection | cisplatin + etoposid | 5 | 56 | 13 | External thmoidectomy | cisplatin + etoposid cisplatin + vinkristin | 10 | 60 | 14 | — | cisplatin + etoposid carboplatin + etoposid | 7 | | 15 | Craniofacial resection | | | | 16 | Craniofacial resection | | | | 17 | Craniofacial resection | Cisplatin | 1 | 70 | 18 | Nasal resection | | | | 19 | Nasal resection | | | 54 |
|
|